Liquidia Co. (NASDAQ:LQDA) CFO Michael Kaseta Sells 23,370 Shares

Liquidia Co. (NASDAQ:LQDA) CFO Michael Kaseta sold 23,370 shares of the business’s stock in a transaction on Tuesday, January 14th. The shares were sold at an average price of $11.78, for a total transaction of $275,298.60. Following the sale, the chief financial officer now directly owns 401,755 shares of the company’s stock, valued at approximately $4,732,673.90. The trade was a 5.50 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Michael Kaseta also recently made the following trade(s):

• On Monday, December 2nd, Michael Kaseta sold 1,091 shares of Liquidia stock. The shares were sold at an average price of $11.51, for a total value of $12,557.41.

Liquidia Stock Up 3.0 %

LQDA opened at $12.51 on Friday. The company has a market capitalization of $1.06 billion, a PE ratio of -7.67 and a beta of 0.23. The firm has a 50-day simple moving average of $11.26 and a two-hundred day simple moving average of $11.03. Liquidia Co. has a 52 week low of $8.26 and a 52 week high of $16.99.

Institutional Investors Weigh In On Liquidia

Hedge funds have recently made changes to their positions in the company. Whitcomb & Hess Inc. increased its stake in Liquidia by 10.2% in the 3rd quarter. Whitcomb & Hess Inc. now owns 11,599 shares of the company’s stock worth $116,000 after acquiring an additional 1,074 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of Liquidia by 10.7% in the second quarter. Arizona State Retirement System now owns 13,842 shares of the company’s stock valued at $166,000 after purchasing an additional 1,341 shares in the last quarter. Quest Partners LLC purchased a new stake in Liquidia during the second quarter valued at $27,000. Profund Advisors LLC lifted its position in Liquidia by 31.6% during the second quarter. Profund Advisors LLC now owns 14,434 shares of the company’s stock valued at $173,000 after purchasing an additional 3,466 shares during the last quarter. Finally, DMC Group LLC grew its stake in shares of Liquidia by 36.7% in the 3rd quarter. DMC Group LLC now owns 13,883 shares of the company’s stock worth $139,000 after buying an additional 3,725 shares in the last quarter. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on LQDA shares. Wells Fargo & Company initiated coverage on Liquidia in a research note on Friday, December 20th. They issued an “overweight” rating and a $20.00 price objective on the stock. HC Wainwright reiterated a “buy” rating and issued a $29.00 price target on shares of Liquidia in a research report on Thursday, November 14th. Scotiabank initiated coverage on shares of Liquidia in a research report on Wednesday, October 16th. They set a “sector outperform” rating and a $30.00 price objective on the stock. Lifesci Capital initiated coverage on shares of Liquidia in a report on Thursday, October 3rd. They issued an “outperform” rating and a $30.00 target price for the company. Finally, Needham & Company LLC reissued a “buy” rating and set a $19.00 price target on shares of Liquidia in a report on Thursday, January 9th. One analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Liquidia has a consensus rating of “Buy” and a consensus price target of $25.38.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).